Sandrine Legg
AstraZeneca (United Kingdom)(GB)AstraZeneca (Singapore)(SG)
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Monoclonal and Polyclonal Antibodies Research, 3D Printing in Biomedical Research, CAR-T cell therapy research, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe(2019)93 cited
- → Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes(2024)14 cited
- → A simeprevir-inducible molecular switch for the control of cell and gene therapies(2023)10 cited
- → A Versatile Polymer‐Based Platform for Intracellular Delivery of Macromolecules(2019)7 cited
- → A novel molecular switch for control of cell and gene therapies based on a clinically approved small molecule(2022)